{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T05:37:47Z","timestamp":1720676267282},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.lpm.2012.03.008","type":"journal-article","created":{"date-parts":[[2012,4,21]],"date-time":"2012-04-21T19:11:31Z","timestamp":1335035491000},"page":"655-661","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P1","title":["Le cardiologue et les immunosuppresseurs"],"prefix":"10.1016","volume":"41","author":[{"given":"Pierre","family":"Ambrosi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Lafforgue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2012.03.008_bib0005","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/01.CIR.0000124490.27666.B2","article-title":"Targeted anticytokine therapy in patients with chronic heart failure. Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)","volume":"109","author":"Mann","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2012.03.008_bib0010","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/CIRCULATIONAHA.107.759191","article-title":"Tumor necrosis factor-alpha and mortality in heart failure: a community study","volume":"118","author":"Dunlay","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2012.03.008_bib0015","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","volume":"107","author":"Chung","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2012.03.008_bib0020","unstructured":"FDA. CDER. Arthritis advisory committee briefing document etanercept and congestive heart failure. 3\u00a0f\u00e9vrier 2003. www.fda.gov."},{"key":"10.1016\/j.lpm.2012.03.008_bib0025","doi-asserted-by":"crossref","first-page":"807","DOI":"10.7326\/0003-4819-138-10-200305200-00008","article-title":"Case reports of heart failure after therapy with a tumor necrosis factor antagonist","volume":"138","author":"Kwon","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2012.03.008_bib0030","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1093\/rheumatology\/kem212","article-title":"Heart failure among younger rheumatoid arthritis and Crohn's patients exposed to TNF-\u03b1 antagonists","volume":"46","author":"Curtis","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.lpm.2012.03.008_bib0035","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1136\/ard.2005.043166","article-title":"Safety analysis of adalimumab (Humira) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis","volume":"65","author":"Schiff","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2012.03.008_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2011.07.040","article-title":"Integrated safety analysis: short- and long-term safety profiles of etanercept in patients with psoriasis","author":"Pariser","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.lpm.2012.03.008_bib0045","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/art.20855","article-title":"The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46\u00a0years","volume":"52","author":"Nicola","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2012.03.008_bib0050","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3899\/jrheum.100979","article-title":"The influence of rheumatoid arthritis disease characteristics on heart failure","volume":"38","author":"Myasoedova","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2012.03.008_bib0055","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.amjmed.2003.09.039","article-title":"Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy","volume":"116","author":"Wolfe","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.lpm.2012.03.008_bib0060","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/art.23281","article-title":"Does tumor necrosis factor \u03b1 inhibition promote or prevent heart failure in patients with rheumatoid arthritis","volume":"58","author":"Listing","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2012.03.008_bib0065","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-3083.2009.02296.x","article-title":"A systematic review and meta-analysis of the efficacy and safety of etanercept for treating rheumatoid arthritis","volume":"70","author":"Wiens","year":"2009","journal-title":"Scan J Immunol"},{"issue":"8","key":"10.1016\/j.lpm.2012.03.008_bib0070","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1001\/jama.2011.1211","article-title":"Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials","volume":"306","author":"Ryan","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2012.03.008_bib0075","unstructured":"HAS. Polyarthrite rhumato\u00efde\u00a0: prise en charge en phase d\u2019\u00e9tat. 2007. www.has-sante.fr."},{"key":"10.1016\/j.lpm.2012.03.008_bib0080","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jbspin.2007.10.001","article-title":"Recommendations of the French Society for Rheumatology regardingTNFa antagonist therapy in patients with rheumatoid arthritis","volume":"74","author":"Fautrel","year":"2007","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.lpm.2012.03.008_bib0085","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1600-6143.2011.03504.x","article-title":"Chronic calcineurin-inhibitor nephrotoxicity-lest we forget","volume":"11","author":"Chapman","year":"2011","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.lpm.2012.03.008_bib0090","first-page":"CD007893","article-title":"Effect of cyclosporine on blood pressure","author":"Robert","year":"2010","journal-title":"Cochrane Database System Rev"},{"key":"10.1016\/j.lpm.2012.03.008_bib0095","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00228-010-0902-6","article-title":"Tacrolimus versus cyclosporine as primary immununosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomized trials","volume":"66","author":"Penninga","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.lpm.2012.03.008_bib0100","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.transproceed.2008.11.016","article-title":"Tacrolimus versus cyclosporine for adult lung transplant recipients: a meta-analysis","volume":"41","author":"Fan","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.lpm.2012.03.008_bib0105","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/01.CIR.0000151609.60618.3C","article-title":"Drug therapy in the heart transplant recipient: part III: common medical problems","volume":"111","author":"Lindenfeld","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2012.03.008_bib0110","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1524-6175.2007.06588.x","article-title":"Hypertension after renal transplant","volume":"9","author":"Tedla","year":"2007","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.lpm.2012.03.008_bib0115","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1053\/jlts.2001.28511","article-title":"Hypertension and renal dysfunction in long-term liver transplant recipients","volume":"7","author":"Gonwa","year":"2001","journal-title":"Liver Transplant"},{"issue":"Suppl. 4","key":"10.1016\/j.lpm.2012.03.008_bib0120","first-page":"1","article-title":"European best practice guidelines for renal transplantation. Section IV: long-term management of the transplant recipient","volume":"17","author":"Expert Group on Renal EBPG.","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.lpm.2012.03.008_bib0125","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1016\/S0041-1345(02)03695-3","article-title":"Prevalence and significance of renal artery stenosis and abdominal aortic atherosclerosis early after heart transplantation","volume":"34","author":"Bolad","year":"2002","journal-title":"Transplant proc"},{"key":"10.1016\/j.lpm.2012.03.008_bib0130","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.CIR.0000151805.86933.35","article-title":"Drug therapy in the heart transplant recipient. Part IV: drug-drug interactions","volume":"111","author":"Page","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2012.03.008_bib0135","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/01.HYP.24.3.297","article-title":"Antihypertensive effect of amlodipine and lack of interference with cyclosporine metabolism in renal transplant recipients","volume":"24","author":"Toupance","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.lpm.2012.03.008_bib0140","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1399-0012.2007.00643.x","article-title":"Enalapril\/amlodipine combination in cyclosporine-treated renal transplant recipients: a prospective randomized trial","volume":"21","author":"Halimi","year":"2007","journal-title":"Clin Transplant"},{"key":"10.1016\/j.lpm.2012.03.008_bib0145","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1681\/ASN.V76831","article-title":"Amlodipine increases cyclosporine levels in hypertensive renal transplant patients: results of a prospective study","volume":"7","author":"Pesavento","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lpm.2012.03.008_bib0150","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/S0041-1345(02)03214-1","article-title":"Gynaecomastia following solid organ transplantation","volume":"34","author":"Fischereder","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1016\/j.lpm.2012.03.008_bib0155","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.transproceed.2005.06.019","article-title":"Switch to tacrolimus for cyclosporine-induced gynecomastia in liver transplant recipients","volume":"37","author":"Iaria","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.lpm.2012.03.008_bib0160","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/0140-6736(92)91199-I","article-title":"Gingival sequestration of nifedipine in nefidipine-induced gingival overgrowth","volume":"339","author":"Ellis","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2012.03.008_bib0165","first-page":"38","article-title":"Gingival enlargement in pediatric organ transplant recipients in relation to tacrolimus-based immunosuppressive regimens","volume":"31","author":"Shiboski","year":"2009","journal-title":"Pediatr Dent"},{"key":"10.1016\/j.lpm.2012.03.008_bib0170","first-page":"540","article-title":"Felodipine in hypertensive heart transplant recipients","volume":"15","author":"Ambrosi","year":"1996","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"10.1016\/j.lpm.2012.03.008_bib0175","first-page":"CD003598","article-title":"Antihypertensive treatment for kidney transplant recipients","author":"Cross","year":"2009","journal-title":"Cochrane Database System Rev"},{"key":"10.1016\/j.lpm.2012.03.008_bib0180","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/0735-1097(96)00057-5","article-title":"Effectiveness and safety of diltiazem or lisinopril in treatment of hypertension after heart transplantation. Results of a prospective, randomized multicenter trail","volume":"27","author":"Brozena","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lpm.2012.03.008_bib0185","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.healun.2010.05.034","article-title":"The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients","volume":"29","author":"Costanzo","year":"2010","journal-title":"J Heart Lung Transplant"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075549821200200X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075549821200200X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T15:54:43Z","timestamp":1642089283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075549821200200X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S075549821200200X"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2012.03.008","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}